ACERINOX SA ADR Earnings Calls
| Release date | May 08, 2026 |
| EPS estimate | $0.588 |
| EPS actual | $0.0100 |
| EPS Surprise | -98.30% |
| Revenue estimate | 3.882B |
| Revenue actual | 1.593B |
| Revenue Surprise | -58.96% |
| Release date | Feb 27, 2026 |
| EPS estimate | $0.0600 |
| EPS actual | -$0.110 |
| EPS Surprise | -283.33% |
| Revenue estimate | 3.874B |
| Revenue actual | 3.175B |
| Revenue Surprise | -18.06% |
| Release date | Oct 31, 2025 |
| EPS estimate | - |
| EPS actual | $0.0600 |
| Revenue estimate | - |
| Revenue actual | 1.657B |
| Release date | Jul 24, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0600 |
| Revenue estimate | 1.663B |
| Revenue actual | 1.774B |
| Revenue Surprise | 6.69% |
Last 4 Quarters for ACERINOX SA ADR
Below you can see how ANIOY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 24, 2025 |
| Price on release | $5.97 |
| EPS estimate | - |
| EPS actual | -$0.0600 |
| Date | Price |
|---|---|
| Jul 18, 2025 | $6.10 |
| Jul 21, 2025 | $6.23 |
| Jul 22, 2025 | $6.25 |
| Jul 23, 2025 | $6.32 |
| Jul 24, 2025 | $5.97 |
| Jul 25, 2025 | $6.32 |
| Jul 28, 2025 | $5.97 |
| Jul 29, 2025 | $5.97 |
| Jul 30, 2025 | $5.87 |
| 4 days before | -2.13% |
| 4 days after | -1.68% |
| On release day | 0% |
| Change in period | -3.77% |
| Release date | Oct 31, 2025 |
| Price on release | $6.22 |
| EPS estimate | - |
| EPS actual | $0.0600 |
| Date | Price |
|---|---|
| Oct 27, 2025 | $6.86 |
| Oct 28, 2025 | $6.86 |
| Oct 29, 2025 | $6.86 |
| Oct 30, 2025 | $6.76 |
| Oct 31, 2025 | $6.22 |
| Nov 03, 2025 | $6.22 |
| Nov 04, 2025 | $6.61 |
| Nov 05, 2025 | $6.61 |
| Nov 06, 2025 | $6.52 |
| 4 days before | -9.33% |
| 4 days after | 4.82% |
| On release day | 0% |
| Change in period | -4.96% |
| Release date | Feb 27, 2026 |
| Price on release | $8.05 |
| EPS estimate | $0.0600 |
| EPS actual | -$0.110 |
| EPS surprise | -283.33% |
| Date | Price |
|---|---|
| Feb 23, 2026 | $7.87 |
| Feb 24, 2026 | $7.87 |
| Feb 25, 2026 | $7.95 |
| Feb 26, 2026 | $7.95 |
| Feb 27, 2026 | $8.05 |
| Mar 02, 2026 | $8.01 |
| Mar 03, 2026 | $8.01 |
| Mar 04, 2026 | $8.01 |
| Mar 05, 2026 | $8.01 |
| 4 days before | 2.29% |
| 4 days after | -0.497% |
| On release day | -0.497% |
| Change in period | 1.78% |
| Release date | May 08, 2026 |
| Price on release | $8.63 |
| EPS estimate | $0.588 |
| EPS actual | $0.0100 |
| EPS surprise | -98.30% |
| Date | Price |
|---|---|
| May 04, 2026 | $8.13 |
| May 05, 2026 | $8.58 |
| May 06, 2026 | $8.58 |
| May 07, 2026 | $8.63 |
| May 08, 2026 | $8.63 |
| May 11, 2026 | $8.49 |
| May 12, 2026 | $8.25 |
| May 13, 2026 | $8.53 |
| May 14, 2026 | $8.48 |
| 4 days before | 6.15% |
| 4 days after | -1.69% |
| On release day | -1.62% |
| Change in period | 4.35% |
ACERINOX SA ADR Earnings Call Transcript Summary of Q1 2026
Acerinox reported a constructive Q1 2026 despite geopolitical uncertainty and elevated energy/logistics costs. Key operational highlights: melting production rose 22% quarter-over-quarter, sales improved ~6%, and adjusted EBITDA reached EUR 119 million (up 18% vs Q4 2025). Operating cash flow remained positive (EUR 34 million) with working capital only up EUR 47 million, despite higher volumes and raw material prices. Net financial debt increased by about EUR 100–106 million after dividends and EUR 73 million of Q1 CapEx; the group is mid-cycle on substantial investment programs (notably NAS in the U.S. and Haynes/HPA in the U.S.). Market commentary: North America remains the strongest and most protected market (higher prices and effective alloy surcharge pass-through), Europe is improving but demand is still weak and pass-through is less effective, and HPA (high-performance alloys) is at a trough in some segments (oil & gas/chemicals) while aerospace and gas turbines are showing recovery and stronger order intake (Haynes saw record order entries in April). Management reiterated balance-sheet strength, the strategic focus on diversification (geography and product), continued execution of productivity program 'Beyond Excellence', and that preparations are underway to study a potential U.S. listing of the North American business (no timing decided). They expect Q2 adjusted EBITDA to be higher than Q1 and see breakeven in European operations as achievable later in 2026 (likely in H2).
Sign In
Buy ANIOY